SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 73 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 101 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 101 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 101 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 101 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 101 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 101 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 101 | -62.6% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -33.3% | 270 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | +50.0% | 270 | +22.7% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 220 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |